Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-05-17
2011-05-17
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S393000
Reexamination Certificate
active
07943621
ABSTRACT:
The present invention relates to novel monohydrochloride, dihydrochloride, monohydrobromide, maleate and methanesulphonate salts of trans 4-{2-[4-(2,3-dichlorophenyl)-piperazine-1-yl]-ethyl}-N,N-dimethylcarbamoyl-cyclohexylamine and/or their hydrates and/or solvates. Moreover, the invention relates to the process for preparing the salts and their hydrates and/or solvates, to their use in the treatment and/or prevention of conditions which require modulation of dopamine receptor and to pharmaceutical compositions containing them.
REFERENCES:
patent: 7737142 (2010-06-01), Againe Csongor et al.
patent: 2006/0229297 (2006-10-01), Csongor
Berge, et al., Pharmaceutical Salts, J. of Pharm. Sciences (1977).
Levant, “The D3 dopamine receptor: neurobiology and potential clinical relevance,”Pharmacol. Rev., 1997, 49(3):231-252.
Levant et al.,CNS Drugs, 1999, 12:391-.
Levant and McCarson, “D(3) dopamine receptors in rat spinal cord: implications for sensory and motor function,”Neurosci. Lett., 2001, 303:9-12.
Pilla et al., “Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist,”Nature, 1999, 400:371-375.
Schwartz et al., “Dopamine D3 receptor: basic and clinical aspects,”Clin. Neuropharmacol., 1993, 16(4):295-314.
Sokoloff et al., “Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics,”Nature, 1990, 347:146-151.
Wong and Van Tol, “Schizophrenia: from phenomenology to neurobiology,”Neurosci. Biobehav. Rev., 2003, 27(3):269-306.
Againe Csongor Eva
Czibula Laszlo
Domany Gyorgy
Greiner Istvan
Sebok Ferenc
Fish & Richardson P.C.
Leeser Erich A
Richter Gedeon Nyrt.
Wilson James O
LandOfFree
Salts of piperazine compounds as D 3 /D 2 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Salts of piperazine compounds as D 3 /D 2 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Salts of piperazine compounds as D 3 /D 2 antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2683815